12/7/11 – Company May Face 10,000 U.S. Suits Over Diabetes Drug Actos

By Joe Messa

Dec 07

Company May Face 10,000 U.S. Suits Over Diabetes Drug Actos

December 7, 2011 – A group of judges is preparing to decide where cases against the drugmaker Takeda should be consolidated.  Takeda Pharmaceutical Co. could face as many as 10,000 lawsuits over allegations that its top-selling diabetes drug, Actos, causes bladder cancer.

In June, U.S. regulators said that a study showed some users of Actos, the world’s best-selling diabetes medication, faced an increased risk of developing the potentially fatal disease.  There have been 54 suits filed in U.S. federal courts so far.

Actos is a once-a-day pill for Type 2 diabetes.  Studies have shown that the drug has triggered bladder cancer in patients who took the pills daily for years.  For more information about Actos, read our earlier blog post.

Philadelphia defective drug attorneys at Messa & Associates are available to handle cases involving bladder cancer, heart attacks or other injuries related to Actos.  Our attorneys have successfully pursued litigation and obtained verdicts and settlements for victims suffering from these drug product injuries.  If you or a loved one has used the diabetes drug Actos and suffered serious illness or death, please contact us at 1-877-MessaLaw.


About the Author

Joseph L. Messa, Jr. is the founding partner of Messa & Associates, P.C. He is an AV-rated attorney (highest rating available), listed in the Bar Register of Preeminent Lawyers. Read More